Liver cancer care
We offer multi-disciplinary treatment for primary liver cancer (hepatocellular carcinoma — HCC and cholangiocarcinoma — bile duct cancer), as well as the most extensive treatment options available in Canada for treatment of metastatic cancer to the liver. Therapeutic options are discussed with a team of hepatopancreatobiliary surgeons, radiation oncologists, medical oncologist, as well as diagnostic and interventional radiology.
Diagnosis and treatment options
Newly diagnosed with primary liver cancer
- We offer advanced imaging for treatment planning:
- MRI imaging of the liver
- enhanced MRI with novel contrast agents
- contrast enhanced specialized ultrasound
- advanced multi-slice/multi-phasic CT scanning
- We offer surgical treatment:
- Laparoscopic and open liver resection
- Parenchymal Preserving Liver Resection
- Liver Resection combined with ablation
- Image guided surgery with U/S as well as a live hands free imaging system for surgeons
- We offer ablative treatments:
- Radiofrequency ablation
- Microwave ablation
- Focused radiation - stereotactic ablative body radiotherapy (SABR)
- We offer liver directed therapies:
- Embolization
- Chemo-embolization
- We offer systemic therapy:
- Latest targeted molecular agents
Liver metastases from colorectal cancer
- We offer advanced treatment planning including 3D liver volumetrics, specialized MRI imaging, and portal vein embolization (making one side of the liver grow before surgery) where required.
- We offer surgical treatment:
- Laparoscopic and open liver resection
- Parenchymal Preserving Liver Resection
- Liver Resection combined with ablation
- We offer ablative treatments:
- Radiofrequency ablation
- Microwave ablation
- Focused radiation - stereotactic ablative body radiotherapy (SABR)
- We offer liver directed therapies:
- chemoembolization - drug eluting beads with irinotecan (DEBIRI)
- hepatic arterial infusion pump
- We offer systemic therapy:
- Latest chemotherapeutic regimens: first, second, third, fourth line
- Access to clinical trials for novel systemic therapy agents including targeted molecular therapies
Supportive care and information
Clinical trials
We are active in clinical trials of novel therapies.
